Annales de la recherche clinique et de laboratoire

  • ISSN: 2386-5180
  • Indice h du journal: 17
  • Note de citation du journal: 6.26
  • Facteur d’impact du journal: 5.31
Indexé dans
  • Genamics JournalSeek
  • Infrastructure nationale des connaissances en Chine (CNKI)
  • CiteFactor
  • Répertoire d'indexation des revues de recherche (DRJI)
  • Publions
  • Pub européen
  • Google Scholar
  • SHERPA ROMÉO
  • Laboratoires secrets des moteurs de recherche
Partager cette page

Abstrait

Unravelling the Complexities: Advancements and Future Prospects in Drug Development for the Nervous System

Mohammad Ayoub

Clinical drug development is the process of bringing a new medication or therapy from the laboratory to the patient. It involves a series of phases that test the safety and efficacy of the drug in humans, as well as its potential side effects. The first phase of clinical drug development is typically done on a small group of healthy volunteers to determine the safety and dosage of the drug. This is followed by phase II, which involves a larger group of people with the condition the drug is intended to treat, to test its efficacy and optimal dosage